Science Explorer Interactive view Map
Nonprofit · Bonn · Germany

Reference Institute for Bioanalytics

rfb.bioROR OpenAlex
Research works
28
▲ 51% vs 2013–17
Citations
498
17.7 per fractional work
Top-10% rate
27.6%
record average 16.5%
Open access
53%
world 28%

Not ranked overall: Reference Institute for Bioanalytics is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.11× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.99× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 2.55× its world share, 0 worksImmunology and Micro…Neuroscience: 0.44× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 5.35× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.04× its world share, 0 worksChemistryComputer Science: 0.12× its world share, 0 worksComputer ScienceEngineering: 0.06× its world share, 0 worksEngineeringMathematics: 0.29× its world share, 0 worksMathematicsHealth Professions: 0.52× its world share, 0 worksHealth ProfessionsMedicine: 3.67× its world share, 6 worksMedicineDecision Sciences: 0.86× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.40× its world share, 0 worksEconomics, Econometr…Psychology: 0.31× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.3×. Every wedge is a field page.

Which keywords describe research at Reference Institute for Bioanalytics?

By fractional works in all years, weighted toward what it does more of than the world: Fibrosis, Biomarkers, Metabolism, Mass Spectrometry, TGF-ß, Interstitial Lung Disease, Treatment and Endothelial Dysfunction.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 25 words, with their numbers
  1. Fibrosis2▲ 46×6 topics
  2. Biomarkers2▲ 14×5 topics
  3. Epidemiology2▲ 1.71×20 topics
  4. Treatment2▲ 4.7×7 topics
  5. Mass Spectrometry2▲ 25×4 topics
  6. Metabolism2▲ 8.5×6 topics
  7. Interstitial Lung Disease1▲ 89×2 topics
  8. TGF-ß1▲ 29×3 topics
  9. Endothelial Dysfunction1▲ 16×3 topics
  10. Idiopathic Pulmonary Fibrosis1▲ 115×1 topic
  11. Myofibroblast1▲ 115×1 topic
  12. Autoantibodies1▲ 18×3 topics
  13. Immunosuppressive Therapy1▲ 21×2 topics
  14. Oxidative Stress1▲ 2.2×8 topics
  15. Pharmacokinetics1▲ 15×2 topics
  16. Data Analysis1▲ 12×3 topics
  17. Inflammation1▲ 1.64×14 topics
  18. Pulmonary Involvement1▲ 118×1 topic
  19. Systemic Sclerosis1▲ 118×1 topic
  20. TGF-ß Signaling1▲ 58×2 topics
  21. Toxicity1▲ 8.6×2 topics
  22. Aconitum Alkaloids1▲ 174×1 topic
  23. Adaptive Designs1▲ 149×1 topic
  24. False Discovery Rate1▲ 149×1 topic
  25. Traditional Chinese Medicine1▲ 23×1 topic

Which research topics does Reference Institute for Bioanalytics publish most on?

By volume in 2022–2025: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Systemic Sclerosis and Related Diseases, Diabetes Treatment and Management and Erythrocyte Function and Pathophysiology.

Interstitial Lung Diseas…1Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: 1 fractional worksSystemic Sclerosis and R…1Systemic Sclerosis and Related Diseases: 1 fractional worksDiabetes Treatment and Management: 0 fractional worksErythrocyte Function and Pathophysiology: 0 fractional worksClostridium difficile and Clostridium perfringens research: 0 fractional worksCOVID-19 Clinical Research Studies: 0 fractional worksBiosimilars and Bioanalytical Methods: 0 fractional worksBiomedical Ethics and Regulation: 0 fractional worksMedical Imaging and Pathology Studies: 0 fractional worksSARS-CoV-2 and COVID-19 Research: 0 fractional works
Pulmonary and Respiratory MedicinePathology and Forensic MedicineEndocrinology, Diabetes and MetabolismPhysiology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 1 works
  2. 2 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 1 works
  3. 3 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
  4. 4 Erythrocyte Function and Pathophysiology Physiology 0 works
  5. 5 Clostridium difficile and Clostridium perfringens research Infectious Diseases 0 works
  6. 6 COVID-19 Clinical Research Studies Infectious Diseases 0 works
  7. 7 Biosimilars and Bioanalytical Methods Immunology 0 works
  8. 8 Biomedical Ethics and Regulation Physiology 0 works
  9. 9 Medical Imaging and Pathology Studies Pulmonary and Respiratory Medicine 0 works
  10. 10 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.9%not open47.1%

World: 28% of research is openly available.

with international co-authors44.5%domestic only55.5%

World: 19% is written across borders.

How has Reference Institute for Bioanalytics's research output changed?

Output in 2018–2022 was 51% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Bonn

All research institutions in Bonn

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.